VKTX

Conviction 62HealthcareScan · Mon, Aug 10, 2026

Bullish belt hold

VKTX$34.44+0.53%

ResistanceSupportVol 14

Vol MA14 2M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Viking Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.vikingtherapeutics.com ↗

Price34.44

Change+0.53%

Gap-1.08%

Rel volume0.57×

Avg volume1.89M

Avg $ vol65.55M

SMA 2034.96

SMA 5034.32

SMA 20033.79

Price vs 50+0.35%

Price vs 200+1.94%

MA stackbullish

50/200 crossgolden · 8d

Supertrenddown · 37.79

RSI (14)49

MACD hist-0.16

MACD cross—

Stoch %K / %D49 / 43

ADX (14)23

+DI / −DI18 / 23

RSI divergence—

MACD divergence—

ATR %+4.83%

ADR %4.49%

52w high42.13

52w low23.09

From 52w high-18.25%

Above 52w low+49.16%

New 52w highNo

SqueezeOff

Bollinger width21.85%

%B0.43

Donchian pos46.91%

Donchian high38.56

Donchian low30.80

AVWAP (52w high)33.67

vs AVWAP high+2.29%

AVWAP (52w low)33.14

vs AVWAP low+3.91%

OBV trendDown

Chaikin MF (20)-0.09

Today vs 20d0.57×

Avg vol (14d)2M

Avg vol (20d)1.89M

Avg $ vol (20d)65.55M

Market cap4.02B

RS 3m (vs SPY)+2.79%

RS 6m (vs SPY)+16.20%

RS line new highNo

Trend template6/8

Technical rank51.5

1 week+5.61%

1 month-11.37%

3 months+9.93%

6 months+21.10%

1 year-3.15%

YTD-2.77%

P/E-11.17

P/B9.84

P/S—

P/FCF—

EPS-3.19

Div yield—

ROE-88.08%

ROA-68.91%

Debt/Eq—

Current4.72

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-227.05%

Price target92.08

Target upside167.36%

Analyst ratingBuy

Institutional74.50%

Ent. value3.89B

Revenue0

Net income-128.02M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out116.11M

Employees59

ListedWed, Apr 29, 2015

Free float111.83M

Float %96.8%

Short interest23.16M

Days to cover9.8d

Short volume45.7%

Squeeze score69 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.10 vs −$1.21

Last surprise+9.1% beat

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank51.5 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VKTX

All disclosures →

No recent disclosed trades by Congress in VKTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VKTX · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Kelly-Gemmell Dorothy Elizabeth Director · Common Stock, par value $0.00001 per share · 2026-08-01	Grant	6.33K	—	2026-08-01	2026-08-07
Kelly-Gemmell Dorothy Elizabeth Director · Stock Option (Right to Buy) · 2026-08-01	Grant	40.8K	—	2026-08-01	2026-08-07
Chen Hubert C Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-01	Grant	190K	$0	2026-06-01	2026-06-03

SEC filings

EDGAR filings in VKTX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.